Epidemiology of sarcoidosis: Recent advances and future prospects

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 1, 2007, Pages 22-35

  Rybicki, Benjamin A ^a   Iannuzzi, Michael C ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Environmental exposure; Epidemiology; Etiology; Genetics; Sarcoidosis

Indexed keywords

HLA DR ANTIGEN;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; ENVIRONMENTAL EXPOSURE; GENE INTERACTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS;

AFRICAN AMERICANS; ENVIRONMENTAL EXPOSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GRANULOMA, RESPIRATORY TRACT; HLA-DQ ANTIGENS; HUMANS; INCIDENCE; LINKAGE (GENETICS); PHENOTYPE; RISK FACTORS; SARCOIDOSIS, PULMONARY;

EID: 33847732254     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970331     Document Type: Article

References (120)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755
2. ACCESS Group. Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. J Clin Epidemiol 1999;52:1173-1186
3. Semenzato G. ACCESS: a case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:83-86
4. Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003;73:720-735
5. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164:2085-2091
6. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-1330
7. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003;167:1225-1231
8. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005;37:357-364
9. Hizawa N, Yamaguchi E, Furuya K, Jinushi E, Ito A, Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999;159:2021-2023
10. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 2005;77:491-499
11. Pandey JP, Frederick M. TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immunol 2002;63:485-491
12. Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int J Immunogenet 2006;33:135-140
13. Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, Fakiola M, Nancy ME, Blackwell JM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet 2005;13:829-834
14. Foley PJ, Lympany PA, Puscinska E, Zielinski J, Welsh KI, du Bois RM. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med 1999;160:1009-1014
15. Gazouli M, Koundourakis A, Ikonomopoulos J, et al. CARD15/NOD2, CD14, and Toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006;23:23-29
16. Zorzetto M, Bombieri C, Ferrarotti I, et al. Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 2002;27:17-23
17. Takada T, Suzuki E, Morohashi K, Gejyo F. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 2002;60:36-42
18. Akahoshi M, Ishihara M, Remus N, et al. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 2004;114:S03-S09
19. Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003;123:1520-1526
20. Rybicki BA, Major M, Popovich JJ, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-241
21. Yamaguchi M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan: recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 1989;6:138-146
22. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis 1984;130:29-32
23. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986;123:840-845
24. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994: a registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:46-52
25. Furuya K, Yamaguchi E, Itoh A, et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 1996;51:777-780
26. Kruit A, Ruven HJ, Grutters JC, Van Den Bosch JM. Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:195-203
27. Rybicki BA, Kirkey KL, Major M, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001;153:188-193
28. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889
29. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:204-211
30. Terris M, Chavis AD. An epidemiologic study of sarcoidosis. Am Rev Respir Dis 1966;94:50-55
31. Buck AA, Sartwell PE. Epidemiologic investigations of sarcoidosis, II: Skin sensitivity and environmental factors. Am J Hyg 1961;74:152-173
32. Cummings MM, Hudgins PC. Chemical constituents of pine pollen and their possible relationship to sarcoidosis. Am J Med Sci 1958;236:311-317
33. Burdick KH. Cutaneous reaction to pine pollen in sarcoidosis: study of forty cases. J Invest Dermatol 1964;42:449-451
34. Gentry JT, Nitowsky HM, Michael MJr. Studies on the epidemiology of sarcoidosis in the United States: the relationship to soil areas and to urban-rural residence. J Clin Invest 1955;34:1839-1856
35. Comstock GW, Keltz H, Sencer J. Clay eating and sarcoidosis: a controlled study in the state of Georgia. Am Rev Respir Dis 1961;84:130-134
36. Hurley HJ, Close HP, English RS. Soil extracts as antigens in sarcoidosis. Am Rev Respir Dis 1962;86:100-102
37. Kajdasz DK, Lackland DT, Mohr LC, Judson MA. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 2001;11:111-117
38. Drent M, Bomans PH, Van Suylen RJ, Lamers RJ, Bast A, Wouters EF. Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med 2000;94:815-820
39. Rafnsson V, Ingimarsson O, Hjalmarsson I, Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 1998;55:657-660
40. Rybicki BA, Amend KL, Maliarik MJ, Iannuzzi MC. Photocopier exposure and risk of sarcoidosis in African-American sibs. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:49-55
41. Kucera GP, Rybicki BA, Kirkey KT, et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest 2003;123:1527-1535
42. Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in navy personnel: a 27-year historical prospective study, 1975-2001. Chest 2004;126:1431-1438
43. Barnard J, Rose C, Newman L, et al. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (ACCESS). J Occup Environ Med 2005;47:226-234
44. Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 1999;116:1183-1193
45. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148:974-980
46. Falkinham JO III. Mycobacterial aerosols and respiratory disease. Emerg Infect Dis 2003;9:763-767
47. Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 2006;73:20-26
48. Vokurka M, Lecossier D, du Bois RM, et al. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997;156:1000-1003
49. Brown ST, Brett I, Almenoff PL, Lesser M, Terrin M, Teirstein AS. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 2003;123:413-417
50. du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003;253:4-17
51. Drake WP, Newman LS. Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 2006;12:359-363
52. Buck AA, McKusick VA. Epidemiologic investigations of sarcoidosis, III: Serum proteins, syphilis, association with tuberculosis: familial aggregation. Am J Hyg 1961;74:174-188
53. Headings VE, Weston D, Young RCJ, Hackney RLJ. Familial sarcoidosis with multiple occurrences in eleven families: a possible mechanism of inheritance. Ann NY Acad Sci 1976;278:377-385
54. McGrath DS, Daniil Z, Foley P, et al. Epidemiology of familial sarcoidosis in the UK. Thorax 2000;55:751-754
55. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Müller-Quernheim J, Schwinger E. Results from a genomewide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164:840-846
56. Rybicki BA, Hirst K, Iyengar SK, et al. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:115-122
57. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and marker locus. Behav Genet 1972;2:3-19
58. Iannuzzi MC, Iyengar SK, Gray-McGuire C, et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005;6:509-518
59. Gray-McGuire C, Sinha R, Iyengar S, et al. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet. In press
60. Thompson CL, Rybicki BA, lannuzzi MC, et al. Reduction of sample heterogeneity through use of population substructure: an example from a population of African American families with sarcoidosis. Am J Hum Genet 2006;79:606-613
61. Petrek M, Drabek J, Kolek V, et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;162:1000-1003
62. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 2 and sarcoidosis: association with Löfgren's syndrome. Am J Respir Crit Care Med 2003;168:1162-1166
63. Valentonyte R, Hampe J, Croucher PJ, et al. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family based analysis. Am J Respir Crit Care Med 2005;11:1136-1141
64. Li Y, Wollnik B, Pabst S, et al. BTNL2 gene variant and sarcoidosis. Thorax 2006;61:273-274
65. Brewerton DA, Cockburn C, James DC, James DG, Neville E. HLA antigens in sarcoidosis. Clin Exp Immunol 1977;27:227-229
66. Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis. Tissue Antigens 1983;22:200-203
67. Mrazek F, Holla LI, Hutyrova B, et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005;65:163-171
68. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601-1605
69. Swider C, Schnittger L, Bogunia-Kubik K, et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999;10:143-146
70. Sato H, Grutters JC, Pantelidis P, et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002;27:406-412
71. Lofgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946;124:1-197
72. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004;169:696-702
73. Martinetti M, Tinelli C, Kolek V, et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995;152:557-564
74. Papadopoulos KI, Melander O, Orho-Melander M, Groop LC, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 2000;247:71-77
75. Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999;13:723-726
76. Maliarik MJ, Rybicki BA, Malvitz E, et al. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998;158:1566-1570
77. Niimi T, Tomita H, Sato S, et al. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients. Chest 1998;114:495-499
78. Ohchi T, Shijubo N, Kawabata I, et al. Polymorphism of Clara cell 10-kD protein gene of sarcoidosis. Am J Respir Crit Care Med 2004;169:180-186
79. Janssen R, Sato H, Grutters JC, et al. The Clara cell10 adenine38guanine polymorphism and sarcoidosis susceptibility in Dutch and Japanese subjects. Am J Respir Crit Care Med 2004;170:1185-1187
80. Hattori N, Niimi T, Sato S, et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:27-32
81. Naruse TK, Matsuzawa Y, Ota M, et al. HLA-DQB1"0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 2000;56:52-57
82. Voorter CE, Drent M, van den Berg-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1"0602-DRB1"150101. Hum Immunol 2005;66:826-835
83. Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 2003;29:225-231
84. Grutters JC, Sato H, Pantelidis P, et al. Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:20-27
85. Abdallah A, Sato H, Grutters JC, et al. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 2003;4:450-454
86. Hill MR, Papafili A, Booth H, et al. Functional prostaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006;174:915-922
87. Pabst S, Baumgarten G, Stremmel A, et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006;143:420-426
88. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002;165:1119-1124
89. Labunski S, Posern G, Ludwig S, Kundt G, Brocker EB, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001;81:18-21
90. Takashige N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999;54:191-193
91. Seitzer U, Swider C, Stuber F, et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997;9:787-790
92. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001;119:753-761
93. Kreider ME, Christie JD, Thompson B, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005;128:207-215
94. Grutters JC, Sato H, Welsh KI, du Bois RM. The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 2003;29:S59-S62
95. Yamada R, Ymamoto K. Recent findings on genes associated with inflammatory disease. Mutat Res 2005;573:136-151
96. Rybicki BA, Sinha R, Iyengar S, Gray-McGuire C, Elston RC, Iannuzzi M.C.S.A. Study Consortium. Genetic linkage analysis of sarcoidosis phenotypes: the Sarcoidosis Genetic Analysis (SAGA) Study. Genet Immun. In press
97. Hills SE, Parkes SA, Baker SB. Epidemiology of sarcoidosis in the Isle of Man, II: Evidence for space-time clustering. Thorax 1987;42:427-430
98. Edmondstone WM, Wilson AG. Temporal clustering of familial sarcoidosis in non-consanguineous relatives. Br J Dis Chest 1984;78:184-186
99. Visser H, Vos K, Zanelli E, et al. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis 2002;61:499-504
100. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-153
101. Wacholder S, Hartge P, Struewing JP, et al. The kin-cohort study for estimating penetrance. Am J Epidemiol 1998;148:623-630
102. Saunders CL, Begg CB. Kin-cohort evaluation of relative risks of genetic variants. Genet Epidemiol 2003;24:220-229
103. Gail MH, Pee D, Carroll R. Kin-cohort designs for gene characterization. J Natl Cancer Inst Monogr 1999:55-60
104. Rybicki BA, Elston RC. The relationship between the sibling recurrence-risk ratio and genotype relative risk. Am J Hum Genet 2000;66:593-604
105. Umbach DM, Weinberg CR. Designing and analysing case-control studies to exploit independence of genotype and exposure. Stat Med 1997;16:1731-1743
106. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!. Am J Epidemiol 1996;144:207-213
107. Albert PS, Ratnasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol 2001;154:687-693
108. Gatto NM, Campbell UB, Rundle AG, Ahsan H. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. Int J Epidemiol 2004;33:1014-1024
109. Gundelfinger BF, Britten SA. Sarcoidosis in the United States Navy. Am Rev Respir Dis 1961;84(suppl):109-115
110. Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol 1974;99:250-257
111. Benatar SR. Sarcoidosis in South Africa: a comparative study in whites, blacks and coloureds. S Afr Med J 1977;52:602-606
112. Edmondstone WM, Wilson AG. Sarcoidosis in Caucasians, blacks and Asians in London. Br J Dis Chest 1985;79:27-36
113. Parra EJ, Marcini A, Akey J, et al. Estimating African-American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998;63:1839-1851
114. McKeigue PM, Carpenter JR, Parra EJ, Shriver MD. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet 2000;64:171-186
115. Smith MW, O'Brien SJ. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet 2005;6:623-632
116. Stephens JC, Briscoe D, O'Brien SJ. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. Am J Hum Genet 1994;55:809-824
117. Rybicki BA, Iyengar SK, Harris T, et al. The distribution of long range admixture linkage disequilibrium in an African-American population. Hum Hered 2002;53:187-196
118. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MFA. Genome-wide SNP panel with high ancestry information for African-American admixture mapping. Am J Hum Genet 2006;79:640-649
119. Smith MW, Patterson N, Lautenberger JA, et al. A high-density admixture map for disease gene discovery in African-Americans. Am J Hum Genet 2004;74:1001-1013
120. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001;285:540-544